Showing results (1521-1530 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|September 9, 2021
Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation-A Matched-Pair AnalysisSouichi Shiratori, Mio Kurata, Junichi Sugita, et al.
Transplantation and Cellular Therapy|August 17, 2021
Feasibility and Efficacy of a Pharmacokinetics-Guided Busulfan Conditioning Regimen for Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Adult Patients with Hematologic MalignanciesStefania Bramanti, Chiara De Philippis, Antonella Bartoli, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Transplantation and Cellular Therapy|August 18, 2021
Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor TransplantationHemalatha G Rangarajan, Marcelo S F Pereira, Ruta Brazauskas, et al.
Transplantation and Cellular Therapy|August 3, 2022
Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood TransplantationShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Transplantation and Cellular Therapy|August 24, 2022
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical TrialAnne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, et al.
Transplantation and Cellular Therapy|May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell TransplantationNatasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Transplantation and Cellular Therapy|June 6, 2021
Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control StudyLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Pageof 183